{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]P15056,1,P15056,96,1]["},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P15056","source":"P15056|Serine/threonine-protein kinase B-raf","targets":["1UWH|The complex of wild type B-RAF and BAY439006.|X-RAY DIFFRACTION|2.95|HOMO SAPIENS|0|TRANSFERASE","1UWJ|The complex of mutant V599E B-RAF and BAY439006.|X-RAY DIFFRACTION|3.5|HOMO SAPIENS|0|TRANSFERASE","2FB8|Structure of the B-Raf kinase domain bound to SB-590885|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSFERASE","2L05|Solution NMR Structure of the Ras-binding domain of Serine/threonine-protein kinase B-raf from Homo sapiens, Northeast Structural Genomics Consortium Target HR4694F|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","3C4C|B-Raf Kinase in Complex with PLX4720|X-RAY DIFFRACTION|2.57|Homo sapiens|0|TRANSFERASE","3D4Q|Pyrazole-based inhibitors of B-Raf kinase|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE","3IDP|B-Raf V600E kinase domain in complex with an aminoisoquinoline inhibitor|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE","3II5|The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor|X-RAY DIFFRACTION|2.79|Homo sapiens|0|TRANSFERASE","3NY5|Crystal structure of the RBD domain of serine/threonine-protein kinase B-raf from Homo sapiens. Northeast Structural Genomics Consortium Target HR4694F|X-RAY DIFFRACTION|1.993|Homo sapiens|0|TRANSFERASE","3OG7|B-Raf Kinase V600E oncogenic mutant in complex with PLX4032|X-RAY DIFFRACTION|2.45|Homo sapiens|0|transferase/transferase inhibitor","3PPJ|Human B-Raf Kinase in Complex with a Furopyridine Inhibitor|X-RAY DIFFRACTION|3.7|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3PPK|Human B-Raf Kinase in Complex with a Non-Oxime Furopyridine Inhibitor|X-RAY DIFFRACTION|3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3PRF|Crystal Structure of Human B-Raf Kinase Domain in Complex with a Non-Oxime Furopyridine Inhibitor|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3PRI|Crystal Structure of Human B-Raf Kinase in Complex with a Non-Oxime Furopyridine Inhibitor|X-RAY DIFFRACTION|3.5|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3PSB|Furo[2,3-c]pyridine-based Indanone Oximes as Potent and Selective B-Raf Inhibitors|X-RAY DIFFRACTION|3.4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3PSD|Non-oxime pyrazole based inhibitors of B-Raf kinase|X-RAY DIFFRACTION|3.6|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3Q4C|Crystal Structure of Wild Type BRAF kinase domain in complex with organometallic inhibitor CNS292|X-RAY DIFFRACTION|3.2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3Q96|B-Raf kinase domain in complex with a tetrahydronaphthalene inhibitor|X-RAY DIFFRACTION|3.1|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3SKC|Human B-Raf Kinase in Complex with an Amide Linked Pyrazolopyridine Inhibitor|X-RAY DIFFRACTION|3.2|Homo sapiens|0|Transferase/Transferase Inhibitor","3TV4|Human B-Raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor|X-RAY DIFFRACTION|3.4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3TV6|Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor|X-RAY DIFFRACTION|3.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4CQE|B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf Inhibitor|X-RAY DIFFRACTION|2.3|HOMO SAPIENS|0|TRANSFERASE","4DBN|Crystal Structure of the Kinase domain of Human B-raf with a [1,3]thiazolo[5,4-b]pyridine derivative|X-RAY DIFFRACTION|3.15|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4E26|BRAF in complex with an organic inhibitor 7898734|X-RAY DIFFRACTION|2.55|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4E4X|Crystal Structure of B-Raf Kinase Domain in Complex with a Dihydropyrido[2,3-d]pyrimidinone-based Inhibitor|X-RAY DIFFRACTION|3.6|Homo sapiens|0|Transferase/Transferase Inhibitor","4EHE|B-Raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor|X-RAY DIFFRACTION|3.3|Homo sapiens|0|Transferase/Transferase Inhibitor","4EHG|B-Raf Kinase Domain in Complex with an Aminopyridimine-based Inhibitor|X-RAY DIFFRACTION|3.5|Homo sapiens|0|Transferase/Transferase Inhibitor","4FC0|Crystal Structure of Human Kinase Domain of B-raf with a DFG-out Inhibitor|X-RAY DIFFRACTION|2.95|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4FK3|B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203|X-RAY DIFFRACTION|2.65|Homo sapiens|0|Transferase/Transferase inhibitor","4G9C|Human B-Raf Kinase Domain bound to a Type II Pyrazolopyridine Inhibitor|X-RAY DIFFRACTION|3.5|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4G9R|B-Raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor|X-RAY DIFFRACTION|3.2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4H58|BRAF in complex with compound 3|X-RAY DIFFRACTION|3.1|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4JVG|B-Raf Kinase in Complex with Birb796|X-RAY DIFFRACTION|3.09|Homo sapiens|0|Transferase/transferase inhibitor","4KSP|Crystal Structure of Human B-raf bound to a DFG-out Inhibitor TAK-632|X-RAY DIFFRACTION|2.93|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4KSQ|Crystal Structure of Human B-raf bound to a DFG-out Inhibitor 5B|X-RAY DIFFRACTION|3.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4MBJ|Human B-Raf Kinase Domain in Complex with an Imidazopyridine-based Inhibitor|X-RAY DIFFRACTION|3.6|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4MNE|Crystal structure of the BRAF:MEK1 complex|X-RAY DIFFRACTION|2.8483|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4MNF|Crystal structure of BRAF-V600E bound to GDC0879|X-RAY DIFFRACTION|2.802|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4PP7|Highly Potent and Selective 3-N-methylquinazoline-4(3H)-one Based Inhibitors of B-RafV600E Kinase|X-RAY DIFFRACTION|3.4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4R5Y|The complex structure of Braf V600E kinase domain with a novel Braf inhibitor|X-RAY DIFFRACTION|3.5|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4RZV|Crystal structure of the BRAF (R509H) kinase domain monomer bound to Vemurafenib|X-RAY DIFFRACTION|2.994|Homo sapiens|0|Transferase/Transferase Inhibitor","4RZW|Crystal structure of BRAF (R509H) kinase domain bound to AZ628|X-RAY DIFFRACTION|3.493|Homo sapiens|0|Transferase/Transferase Inhibitor","4WO5|Crystal structure of a BRAF kinase domain monomer|X-RAY DIFFRACTION|2.83|Homo sapiens|0|TRANSFERASE/TRANSFERASE Inhibitor","4XV1|B-Raf Kinase V600E oncogenic mutant in complex with PLX7904|X-RAY DIFFRACTION|2.47|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4XV2|B-Raf Kinase V600E oncogenic mutant in complex with Dabrafenib|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4XV3|B-Raf Kinase V600E oncogenic mutant in complex with PLX7922|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4XV9|B-Raf Kinase domain in complex with PLX5568|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4YHT|bRaf complexed with an inhibitor|X-RAY DIFFRACTION|3.05|Homo sapiens|0|Transferase/Transferase Inhibitor","5C9C|CRYSTAL STRUCTURE OF BRAF(V600E) IN COMPLEX WITH LY3009120 COMPND|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5CSW|B-RAF in complex with Dabrafenib|X-RAY DIFFRACTION|2.66|Homo sapiens|0|TRANSFERASE","5CSX|CRYSTAL STRUCTURE OF B-RAF IN COMPLEX WITH BI 882370|X-RAY DIFFRACTION|2.51|Homo sapiens|0|TRANSFERASE","5CT7|BRAF in Complex with RAF265|X-RAY DIFFRACTION|3.17|Homo sapiens|0|TRANSFERASE","5FD2|B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor|X-RAY DIFFRACTION|2.89|Homo sapiens|0|Transferase/Transferase Inhibitor","5HI2|BRAF Kinase domain b3aC loop deletion mutant in complex with sorafenib|X-RAY DIFFRACTION|2.512|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5HID|BRAF Kinase domain b3aC loop deletion mutant in complex with AZ628|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5HIE|BRAF Kinase domain b3aC loop deletion mutant in complex with dabrafenib|X-RAY DIFFRACTION|3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5ITA|Crystal Structure of BRAF Kinase Domain Bound to AZ-VEM|X-RAY DIFFRACTION|1.95|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5J17|Solution structure of Ras Binding Domain (RBD) of B-Raf|SOLUTION NMR||Homo sapiens|0|PROTEIN BINDING","5J18|Solution structure of Ras Binding Domain (RBD) of B-Raf complexed with Rigosertib (Complex I)|SOLUTION NMR||Homo sapiens|0|PROTEIN BINDING","5J2R|Solution structure of Ras Binding Domain (RBD) of B-Raf|SOLUTION NMR||Homo sapiens|0|PROTEIN BINDING","5JRQ|BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-6-VEM|X-RAY DIFFRACTION|2.287|Homo sapiens|0|TRANSFERASE/TRANSFERASE inhibitor","5JSM|BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM|X-RAY DIFFRACTION|2.19|Homo sapiens|0|TRANSFERASE/TRANSFERASE inhibitor","5JT2|BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE|X-RAY DIFFRACTION|2.702|Homo sapiens|0|TRANSFERASE/TRANSFERASE inhibitor","5VAL|BRAF in Complex with N-(3-(tert-butyl)phenyl)-4-methyl-3-(6-morpholinopyrimidin-4-yl)benzamide|X-RAY DIFFRACTION|2.26|Homo sapiens|0|TRANSFERASE/TRANSFERASE inhibitor","5VAM|BRAF in Complex with RAF709|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE/TRANSFERASE inhibitor","5VR3|Crystal structure of the BRS domain of BRAF|X-RAY DIFFRACTION|2.102|Homo sapiens|0|TRANSFERASE","5VYK|Crystal structure of the BRS domain of BRAF in complex with the CC-SAM domain of KSR1|X-RAY DIFFRACTION|1.749|Homo sapiens|0|SIGNALING PROTEIN","6B8U|Crystals Structure of B-Raf kinase domain in complex with an Imidazopyridinyl benzamide inhibitor|X-RAY DIFFRACTION|2.68|Homo sapiens|0|Transferase/Transferase Inhibitor","6CAD|Crystal structure of RAF kinase domain bound to the inhibitor 2a|X-RAY DIFFRACTION|2.55|Homo sapiens|0|SIGNALING PROTEIN","6N0P|BRAF in complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (LXH254)|X-RAY DIFFRACTION|2.37|Homo sapiens|0|transferase/transferase inhibitor","6N0Q|BRAF in complex with N-(4-methyl-3-(1-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)phenyl)-3-(trifluoromethyl)benzamide.|X-RAY DIFFRACTION|2.04|Homo sapiens|0|transferase/transferase inhibitor","6NSQ|Crystal structure of BRAF kinase domain bound to the inhibitor 2l|X-RAY DIFFRACTION|3.05|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6NYB|Structure of a MAPK pathway complex|ELECTRON MICROSCOPY|4.1|Homo sapiens; Spodoptera exigua|0|TRANSFERASE","6P3D|The co-crystal structure of BRAF(V600E) with ponatinib|X-RAY DIFFRACTION|2.11|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6P7G|The co-crystal structure of BRAF(V600E) with PHI1|X-RAY DIFFRACTION|2.65|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6PP9|Crystal structure of BRAF:MEK1 complex|X-RAY DIFFRACTION|2.59|Homo sapiens|0|TRANSFERASE","6Q0J|Structure of a MAPK pathway complex|ELECTRON MICROSCOPY|4.9|Homo sapiens; Spodoptera exigua|0|Transferase/PROTEIN BINDING","6Q0K|Structure of a MAPK pathway complex|ELECTRON MICROSCOPY|6.8|Homo sapiens|0|SIGNALING PROTEIN/Transferase","6Q0T|Structure of a MAPK pathway complex|ELECTRON MICROSCOPY|5.7|Homo sapiens; Spodoptera exigua|0|TRANSFERASE/PROTEIN BINDING","6U2G|BRAF-MEK complex with AMP-PCP bound to BRAF|X-RAY DIFFRACTION|2.886|Homo sapiens|0|TRANSFERASE","6U2H|BRAF dimer bound to 14-3-3|X-RAY DIFFRACTION|2.5|Homo sapiens|0|SIGNALING PROTEIN/Transferase","6UAN|B-Raf:14-3-3 complex|ELECTRON MICROSCOPY|3.9|Homo sapiens; Spodoptera aff. frugiperda 1 BOLD-2017|0|SIGNALING PROTEIN","6UUO|Crystal structure of BRAF kinase domain bound to the PROTAC P4B|X-RAY DIFFRACTION|3.288|Homo sapiens|0|SIGNALING PROTEIN","6V2U|Crystal structure of the insect cell-expressed WT-BRAF kinase in complex with Dabrafenib|X-RAY DIFFRACTION|3.78|Homo sapiens|0|TRANSFERASE","6V2W|Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP|X-RAY DIFFRACTION|3.12|Homo sapiens|0|TRANSFERASE","6V34|Crystal structure of BRAF V600E oncogenic mutant in complex with TAK-580|X-RAY DIFFRACTION|3.15|Homo sapiens|0|TRANSFERASE","6XAG|Apo BRAF dimer bound to 14-3-3|X-RAY DIFFRACTION|3.3|Homo sapiens|0|SIGNALING PROTEIN/Transferase","6XFP|Crystal Structure of BRAF kinase domain bound to Belvarafenib|X-RAY DIFFRACTION|2|Homo sapiens|0|SIGNALING PROTEIN","6XLO|Crystal structure of bRaf in complex with inhibitor|X-RAY DIFFRACTION|2.493|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","7K0V|Crystal structure of bRaf in complex with inhibitor GNE-0749|X-RAY DIFFRACTION|1.93|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","7M0T|Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Selumetinib|X-RAY DIFFRACTION|3.19|Homo sapiens|0|TRANSFERASE","7M0U|Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Binimetinib|X-RAY DIFFRACTION|3.09|Homo sapiens|0|TRANSFERASE","7M0V|Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Cobimetinib|X-RAY DIFFRACTION|3.16|Homo sapiens|0|TRANSFERASE","7M0W|Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Pimasertib|X-RAY DIFFRACTION|3.09|Homo sapiens|0|TRANSFERASE","7M0X|Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and PD0325901|X-RAY DIFFRACTION|2.47|Homo sapiens|0|TRANSFERASE","7M0Y|Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Trametinib|X-RAY DIFFRACTION|3.45|Homo sapiens|0|TRANSFERASE","7M0Z|Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and CH5126766|X-RAY DIFFRACTION|3.12|Homo sapiens|0|TRANSFERASE","7MFD|Autoinhibited BRAF:(14-3-3)2:MEK complex with the BRAF RBD resolved|ELECTRON MICROSCOPY|3.66|Homo sapiens|0|SIGNALING PROTEIN/TRANSFERASE","7MFE|Autoinhibited BRAF:(14-3-3)2 complex with the BRAF RBD resolved|ELECTRON MICROSCOPY|4.07|Homo sapiens|0|SIGNALING PROTEIN","7MFF|Dimeric (BRAF)2:(14-3-3)2 complex bound to SB590885 Inhibitor|ELECTRON MICROSCOPY|3.89|Homo sapiens|0|SIGNALING PROTEIN"]}]}